2024;7:e2412345
The market is beginning to bifurcate into those developing dual and triple receptor agonists (GLP-1, GIP, and glucagon) to optimize outcomes and those developing multiple single pathway agonists, which ultimately cannot match the efficacy potential of the multifunctional approach
Its incredibly effective at slowing down hair loss and reactivating follicles that have become dormant, but it works best when there are still viable follicles to stimulate
Although clinical research is in its early stages, emerging data, anecdotal reports, and pharmacoepidemiologic findings suggest these agents may be effective for alcohol, opioid, stimulant, and tobacco use disorders
Due to their popularity, these medications can often be in short supply